Announcement of Resolutions of the 17th Meeting of the 5th Board of Directors of Weili Medical
Securities code: 603309 Securities abbreviation: Weili Medical Announcement number: 2025-060 Guangzhou Weili Medical Equipment Co., Ltd.
Announcement of Resolutions of the 17th Meeting of the Fifth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
1. Convening of board of directors meetings
The meeting notice and materials for the 17th meeting of the fifth board of directors of Guangzhou Weili Medical Devices Co., Ltd. (hereinafter referred to as the "Company") were sent by email on October 11, 2025. The meeting was held at 10 am on October 20, 2025 in the company's conference room through on-site communication and communication. The meeting was chaired by Mr. Xiang Bin, chairman of the board. Seven directors should be present at the meeting and seven directors should be present in person. Among them, independent director Mr. Lu Chunbin and independent director Mr. Zang Chuanbao were on a business trip and participated in this meeting through communication voting. All senior managers of the company attended the meeting. The convening and holding procedures of this meeting complied with the relevant provisions of the Company Law and other relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association. The resolutions formed at the meeting were legal and valid.
2. Review status of board of directors meeting
After careful deliberation by the directors present at the meeting, the following resolutions were unanimously adopted by registered written vote:
(1) "The Company's Third Quarterly Report for 2025"; (For details, please refer to the "Vili Medical's Third Quarterly Report for 2025" published on the same day in "China Securities Journal", "Shanghai Securities News", "Securities Times" and the Shanghai Stock Exchange website (www.sse.com.cn))
The company's third quarter financial report for 2025 has been reviewed and approved at the eighth meeting of the Audit Committee of the fifth session of the board of directors.
Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.
(2) "Proposal on Formulating the "Resignation Management System for Directors and Senior Managers of the Company".
In order to regulate matters related to the resignation of the company's directors and senior managers, ensure the stability and continuity of corporate governance, and safeguard the legitimate rights and interests of the company and shareholders, in accordance with the relevant provisions of the "Company Law of the People's Republic of China" and other laws and regulations, normative documents and the "Articles of Association", and based on the actual situation of the company, the "Company Directors and Senior Managers Resignation Management System" was formulated. (The full text was published on the website of the Shanghai Stock Exchange (http://www.sse.com.cn) on the same day)
Voting results: 7 votes in favor, 0 votes against, and 0 abstentions.
Announcement is hereby made.
Board of Directors of Guangzhou Weili Medical Devices Co., Ltd.
October 21, 2025